ImmunityBio, Inc.
NASDAQ:IBRX
5.3 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -583.196 | -417.32 | -349.848 | -224.187 | -160.158 | -96.226 | -96.423 | -120.809 | -236.876 | -6.213 | -2.047 |
| Depreciation & Amortization
| 18.512 | 18.26 | 14.238 | 12.739 | 14.042 | 9.555 | 5.566 | 3.607 | 1.472 | 0.128 | 0.004 |
| Deferred Income Tax
| 6.476 | -0.004 | -0.008 | -2.938 | -0.008 | -0.498 | -0.497 | -0.575 | -0.302 | 0 | 0 |
| Stock Based Compensation
| 49.163 | 40.179 | 57.181 | 2.187 | 3.421 | 2.043 | 36.997 | 73.852 | 211.221 | 0 | 0 |
| Change In Working Capital
| 3.977 | -8.001 | -19.112 | 16.36 | -15.636 | -0.554 | 3.228 | 3.842 | 0.282 | 60.988 | 0.856 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.458 | 0.075 | 0.095 | -0.173 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -6.476 | 8 | -3.717 | 2.57 | 1.188 | -1.1 | 0.15 | 0.888 | 0.627 | -0.347 | 0.7 |
| Other Working Capital
| 10.453 | -16.001 | -15.395 | 13.79 | -16.824 | 0.546 | 3.078 | 2.954 | -0.42 | 61.24 | 0.329 |
| Other Non Cash Items
| 138.311 | 29.377 | 23.13 | 24.115 | 6.23 | 44.552 | 50.328 | 81.668 | 212.361 | -61.046 | -0.365 |
| Operating Cash Flow
| -366.757 | -337.509 | -274.419 | -171.724 | -152.109 | -63.381 | -48.78 | -38.593 | -25.305 | -5.354 | -0.668 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -30.584 | -99.391 | -33.563 | -1.669 | -4.287 | -13.102 | -34.815 | -6.56 | -2.241 | -0.299 | -0.003 |
| Acquisitions Net
| -0.114 | -1 | 20.498 | 0.008 | 0.2 | 0.412 | -0.032 | -0.137 | -1.818 | 0 | 0 |
| Purchases Of Investments
| -10.358 | -34.312 | -141.75 | -91.765 | -87.192 | -95.493 | -119.855 | -272.999 | -198.068 | 0 | 0 |
| Sales Maturities Of Investments
| 10.472 | 162 | 69.929 | 73.622 | 112.331 | 165.284 | 254.222 | 165.887 | 26.903 | 0 | 0 |
| Other Investing Activites
| 0.114 | 105.459 | -51.323 | -0.008 | -2.5 | 35.026 | 0.032 | 0.137 | -1.818 | 0 | 0 |
| Investing Cash Flow
| -30.47 | 27.297 | -84.886 | -19.812 | 18.552 | 57.101 | 99.552 | -113.672 | -175.224 | -0.299 | -0.003 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -451.387 | -0.058 | -338.5 | -3.941 | -2.276 | -0.477 | -19.932 | -0.032 | -0.132 | -0.053 | -0.001 |
| Common Stock Issued
| 110.397 | 60.427 | 164.53 | 86.302 | 30 | 0.057 | 1.215 | 1.425 | 324.678 | 0 | 0.676 |
| Common Stock Repurchased
| -3.443 | -0.616 | -4.064 | -0.503 | -2.501 | -0.228 | -15.227 | -15.847 | -4.798 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 899.331 | 174.476 | 1,017.913 | 73.261 | 91.332 | -0.123 | -1.039 | -1.106 | -2.415 | 64.46 | 0.23 |
| Financing Cash Flow
| 558.341 | 233.613 | 505.443 | 150.675 | 114.279 | -0.771 | -34.983 | -15.56 | 317.333 | 64.407 | 0.905 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| -0.292 | 0.284 | 0.048 | -0.025 | -0.021 | -0.03 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 160.812 | -76.315 | 146.186 | -40.886 | -19.299 | -7.051 | 15.789 | -167.825 | 116.804 | 58.754 | 0.234 |
| Cash At End Of Period
| 265.453 | 104.965 | 181.28 | 35.094 | 75.98 | 16.821 | 23.872 | 8.083 | 175.908 | 59.104 | 0.35 |